Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Oct 6;12(10):e0185881.
doi: 10.1371/journal.pone.0185881. eCollection 2017.

Effect of lifestyle coaching versus care coordination versus treatment as usual in people with severe mental illness and overweight: Two-years follow-up of the randomized CHANGE trial

Ane Storch Jakobsen  1   2 , Helene Speyer  1   2 , Hans Christian Brix Nørgaard  3   4 , Mette Karlsen  1   2 , Merete Birk  3   4 , Carsten Hjorthøj  1 , Ole Mors  3   5 , Jesper Krogh  1   2 , Christian Gluud  6 , Charlotta Pisinger  7 , Merete Nordentoft  1   2
Affiliations
Randomized Controlled Trial

Effect of lifestyle coaching versus care coordination versus treatment as usual in people with severe mental illness and overweight: Two-years follow-up of the randomized CHANGE trial

Ane Storch Jakobsen et al. PLoS One. .

Abstract

The objective of this trial was to assess the long-term effect of the CHANGE lifestyle coaching intervention for 428 people with abdominal obesity and schizophrenia spectrum disorders on cardiovascular risk. In this randomized, superiority, multi-center clinical trial, participants were randomized to 12 months of either lifestyle coaching plus care coordination (N = 138), care coordination alone, (N = 142) or treatment as usual (N = 148). There was no effect after 12 months, but we hypothesized that there might have been a delayed treatment effect. Our primary outcome at two-year follow-up was 10-year risk of cardiovascular disease standardized to 60 years of age. After two-years the mean 10-year cardiovascular-disease risk was 8.7% (95% confidence interval (CI) 7.6-9.9%) in the CHANGE group, 7.7% (95% CI 6.5-8.9%) in the care coordination group, and 8.9% (95% CI 6.9-9.2%) in the treatment as usual group (P = 0.24). Also, there were no intervention effects for any secondary or exploratory outcomes, including cardiorespiratory fitness, weight, physical activity, diet and smoking. No reported adverse events could be ascribed to the intervention. We conclude that there was neither any direct nor any long-term effect of individual lifestyle coaching or care coordination on cardiovascular risk factors in people with abdominal obesity and schizophrenia spectrum disorders. The trial was approved by the Ethics Committee of Capitol Region Copenhagen, Denmark (registration number: H-4-2012-051) and the Danish Data Protection Agency (registration number: 01689 RHP-2012-007). The trial was funded by the Mental Health Services of the Capital Region of Denmark, the Lundbeck Foundation, the Tryg Foundation, the Danish Ministry of Health, and the Dæhnfeldts Foundation.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Flow diagram showing the process of recruiting and follow up through the CHANGE trial.
See this image and copyright information in PMC

References

    1. DE Hert M. et al. , “Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.,” World Psychiatry, vol. 10, no. 1, pp. 52–77, 2011. - PMC - PubMed
    1. Hjorthøj C., Stürup A. E., Mcgrath J. J., and Nordentoft M., “Years of potential life lost and life expectancy in schizophrenia : a systematic review and meta-analysis,” Lancet Psychiatry, vol. 366, no. published online Feb 21, pp. 1–7, 2017. - PubMed
    1. Bly M. J. et al. , “Metabolic syndrome in bipolar disorder and schizophrenia: Dietary and lifestyle factors compared to the general population,” Bipolar Disord., 2014. - PMC - PubMed
    1. Beary M., Hodgson R., and Wildgust H. J., “A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications,” Journal of Psychopharmacology. 2012. - PubMed
    1. Bruins J., Jörg F., Bruggeman R., Slooff C., Corpeleijn E., and Pijnenborg M., “The effects of lifestyle interventions on (long-term) weight management, cardiometabolic risk and depressive symptoms in people with psychotic disorders: A meta-analysis,” PLoS One, 2014. - PMC - PubMed

Publication types

MeSH terms